These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33749864)

  • 1. The evolution of clinical trials in response to COVID-19.
    Sarah A; Dean O; Berk M
    Med J Aust; 2021 Apr; 214(7):332-332.e1. PubMed ID: 33749864
    [No Abstract]   [Full Text] [Related]  

  • 2. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.
    Heriot GS; Jamrozik E
    Med J Aust; 2021 Mar; 214(4):150-152.e1. PubMed ID: 33550606
    [No Abstract]   [Full Text] [Related]  

  • 3. Inclusion of children and pregnant women in COVID-19 intervention trials.
    Malhotra A; Kumar A; Roehr CC; den Boer MC
    Pediatr Res; 2021 Apr; 89(5):1063-1064. PubMed ID: 32688370
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key steps in our journey to a COVID-19 vaccine program.
    Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
    Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
    [No Abstract]   [Full Text] [Related]  

  • 6. Africa's need for more COVID-19 clinical trials.
    Makoni M
    Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
    [No Abstract]   [Full Text] [Related]  

  • 7. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and changes in the National Immunisation Program: a unique opportunity to optimise the Australian Immunisation Register (AIR).
    Tuckerman J; Blyth CC; Beard FH; Danchin MH
    Med J Aust; 2021 Apr; 214(6):247-249.e1. PubMed ID: 33745151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fight against COVID-19: market overview and pipeline of ongoing trials].
    Pontremoli R; Richard G; Vuddamalay G; Groux N
    Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647
    [No Abstract]   [Full Text] [Related]  

  • 10. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Are COVID-19 Vaccines?
    Hartert TV; Sockrider M
    Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735
    [No Abstract]   [Full Text] [Related]  

  • 12. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193
    [No Abstract]   [Full Text] [Related]  

  • 13. Completion of clinical trials in light of COVID-19.
    Burki TK
    Lancet Respir Med; 2020 Dec; 8(12):1178-1180. PubMed ID: 33010809
    [No Abstract]   [Full Text] [Related]  

  • 14. Tanzania's position on the COVID-19 pandemic.
    Mfinanga SG; Mnyambwa NP; Minja DT; Ntinginya NE; Ngadaya E; Makani J; Makubi AN
    Lancet; 2021 Apr; 397(10284):1542-1543. PubMed ID: 33864748
    [No Abstract]   [Full Text] [Related]  

  • 15. From COVID-19 to COVID-20: One Virus, Two Diseases.
    James JJ
    Disaster Med Public Health Prep; 2020 Dec; 14(6):e18-e20. PubMed ID: 33019951
    [No Abstract]   [Full Text] [Related]  

  • 16. Venezuela is collapsing without COVID-19 vaccines.
    Loyo ESL; González MJ; Esparza J
    Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
    [No Abstract]   [Full Text] [Related]  

  • 17. The race for a COVID-19 vaccine.
    Lavigne SE
    Can J Dent Hyg; 2020 Oct; 54(3):107-109. PubMed ID: 33240370
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 human challenge studies in the UK.
    Kirby T
    Lancet Respir Med; 2020 Dec; 8(12):e96. PubMed ID: 33137284
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Connors M; Graham BS; Lane HC; Fauci AS
    Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?].
    Lanthier L; Carignan A; Plourde MÉ; Cauchon M
    Rev Med Interne; 2021 Mar; 42(3):227-228. PubMed ID: 33612319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.